key: cord-0732272-wnfkbozb
authors: Camporota, Luigi; Chiumello, Davide; Busana, Mattia; Gattinoni, Luciano; Marini, John J
title: Pathophysiology of COVID-19-associated acute respiratory distress syndrome
date: 2020-11-13
journal: Lancet Respir Med
DOI: 10.1016/s2213-2600(20)30505-1
sha: ddff61ebad5c88dd4c2ffa81baf47073194c90f0
doc_id: 732272
cord_uid: wnfkbozb

nan

compared with ARDS from classical aetiologies. This observation indicates that the clinically set PEEP might have been higher than necessary in COVID-19 ARDS, possibly contributing to increased dead space. Accordingly, the authors recommended-correctly, in our view-the use of lower PEEP in patients with COVID-19 ARDS with higher compliance. While the authors' conclusions are strongly supported by the data they present, we are confused by their recommendations to manage ventilation for COVID-19 ARDS similarly to ventilation strategies for classical ARDS. The Article clearly shows key differences between COVID-19 ARDS and classical ARDS that might affect effectiveness and safety. Indeed, because of the disparity between lung mechanics and the oxygenating efficiency that defines ARDS severity, the available evidence would seem to question the necessity of maintaining all standard guidelines (such as setting high PEEP based on PEEP-FiO 2 tables and tightly restricting tidal volume to its lowest range, independent of plateau pressure).

We are strong supporters of ventilation strategies that achieve the maximum degree of lung protection by minimising stress and strain; hence, we think that ventilatory settings for COVID-19 ARDS might need to be adapted in individual cases, depending on mechanical characteristics and timing of presentation. The data regarding compliance and overinflation on CT scan support doing so. Finally, patients with COVID-19 ARDS with lower lung compliance and higher levels of immunothrombosis markers (D-dimers) had greatest mortality risk-presumably despite exposure to a similar ventilation strategy. This observation again highlights the novel pathogenesis and outcome determinants of COVID-19. Anticoagulation and immunomodulation might be key modulators in this ARDS variant. We unequivocally agree with Grasselli and colleagues that following lung protective principles is essential; however, unquestioning adherence to pre-existing ARDS ventilation guidelines might not be warranted at all times in the course of what remains an unfamiliar disease.

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study

Sputnik/Science Photo Library

We declare no competing interests.